Orrin Devinsky

DeFloria LLC, a collaboration between Charlottes Web Holdings Inc (OTCQX:CWBHF) and AJNA BioSciences PBC, has launched the Phase 1 clinical trial of AJA001, a full-spectrum hemp botanical drug. The trial, which marks the first human testing of this innovative substance, began with dosing its first...

Charlotte's Web Holdings, Inc. (OTCQX: CWBHF) (TSX:CWEB) a full-spectrum hemp extract wellness products manufacturer, has formed a joint venture (the "JV") with AJNA BioSciences PBC, a botanical drug development company focused on mental health and neurological disorders, and a...

Receptor Life Sciences (RLS), a pharmaceutical company developing innovative therapies to address central nervous system disorders, recently announced it’s expanding the potential clinical utility of RLS103, a dry powder inhaled cannabidiol (CBD)​​​​​​ into epilepsy treatment. Dry...

Shares of GW Pharmaceuticals PLC-ADR (NASDAQ: GWPH) are up nearly 120 percent in early Monday trading after the company announced positive Phase III data on Epidiolex. The study found that the drug significantly reduced seizures in children suffering from Dravet Syndrome, a condition for which...

Shares of GW Pharmaceuticals PLC - ADR (NASDAQ: GWPH) spiked higher by more than 5 percent early Thursday morning after the company reported that data from a physician-led study into Epidiolex "reduced seizure frequency" across multiple drug-resistant epilepsy syndromes and seizure types and was "...